![Colin Hunter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Colin Hunter
Président chez Royal College of General Practitioners
Provenance du réseau au premier degré de Colin Hunter
Entité | Type d'entité | Industrie | |
---|---|---|---|
Leonard Cheshire Disability
![]() Leonard Cheshire Disability Services to the Health IndustryHealth Services Leonard Cheshire Disability provides disability support services. Its services include disability care and support, supported living, domiciliary support, day services, resource centres, rehabilitation, respite care, personal support and training and assistance for those looking for work. The company was founded by Leonard Cheshire on May 22, 1948 and is headquartered in London, the United Kingdom.
35
| Non-Profit Organization | Services to the Health Industry | 35 |
Royal College of General Practitioners
![]() Royal College of General Practitioners Other Consumer ServicesConsumer Services The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings.
15
| Non-Profit Organization | Other Consumer Services | 15 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Colin Hunter via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of Glasgow | College/University | Doctorate Degree Doctorate Degree | |
The University of Southampton | College/University | Undergraduate Degree Corporate Officer/Principal | |
CARETECH HOLDINGS PLC | Medical/Nursing Services | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
The University of Manchester | College/University | Doctorate Degree Doctorate Degree | |
The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
The University of Edinburgh | College/University | Undergraduate Degree Doctorate Degree | |
King's College London | College/University | Undergraduate Degree Doctorate Degree | |
University of Cardiff | College/University | Undergraduate Degree Undergraduate Degree | |
REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harmony Biosciences LLC
![]() Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member | |
Stargazer Pharmaceuticals, Inc.
![]() Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
INOZYME PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Novo Holdings A/S (Investment Company)
![]() Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Corporate Officer/Principal | |
MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member | |
Morphic Therapeutic, Inc.
![]() Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Priory Group Ltd.
![]() Priory Group Ltd. Medical/Nursing ServicesHealth Services Priory Group Ltd. engages in the provision of specialist care and mental health services. It offers acute mental health services, neuro-rehabilitation therapy, specialist education for young people with learning and behavioral difficulties, and complex care services for the elderly. The company was founded on May 8, 2002 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Priory Group No. 3 Ltd.
![]() Priory Group No. 3 Ltd. Other Consumer ServicesConsumer Services Priory Group No. 3 Ltd. provides behavioral care services. It focuses on the provision of acute psychiatry, secure and rehabilitation and recovery services, specialist education, older people care and specialist support for people who have learning difficulties. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Other Consumer Services | Director/Board Member | |
British Medical Association
![]() British Medical Association Miscellaneous Commercial ServicesCommercial Services British Medical Association operates as a trade union and professional body for doctors in the UK. The firm policies cover public health issues, medical ethics, science, the state of the NHS, medical education and doctors’ contracts. It provides medical advice and support services to doctors and health organizations. The company was founded by Charles Hastings in 1832 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
American Society of Hematology
![]() American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
European Society for Medical Oncology
![]() European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal | |
ICON Clinical Research, Inc.
![]() ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
ERGOMED | Miscellaneous Commercial Services | President | |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director/Board Member | |
Nuvelution Pharma, Inc.
![]() Nuvelution Pharma, Inc. BiotechnologyHealth Technology Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
ReNeuron Ltd.
![]() ReNeuron Ltd. BiotechnologyHealth Technology ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom. | Biotechnology | Chief Executive Officer | |
University of Durham | College/University | Undergraduate Degree | |
The Chartered Institute For Securities & Investment
![]() The Chartered Institute For Securities & Investment General GovernmentGovernment The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom. | General Government | Corporate Officer/Principal | |
The University of Hull | College/University | Corporate Officer/Principal | |
Vantia Ltd.
![]() Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
The Bioindustry Association
![]() The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Scandinavian International Management Institute | College/University | Corporate Officer/Principal | |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
Tarsa Therapeutics, Inc.
![]() Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
RENEURON GROUP PLC | Pharmaceuticals: Major | Chief Executive Officer | |
University of Warwick | College/University | Masters Business Admin |
Statistiques
Internationale
Royaume-Uni | 27 |
Etats-Unis | 21 |
Danemark | 4 |
Suisse | 2 |
Sectorielle
Health Technology | 26 |
Consumer Services | 13 |
Commercial Services | 7 |
Health Services | 5 |
Finance | 3 |
Opérationnelle
Director/Board Member | 116 |
Corporate Officer/Principal | 75 |
Chairman | 38 |
Chief Tech/Sci/R&D Officer | 27 |
Independent Dir/Board Member | 22 |
Relations les plus connectées
Insiders | |
---|---|
Martin Edwards | 38 |
Neil Geoffrey Goulden | 32 |
Cameron Durrant | 25 |
John Standen | 20 |
David Richard Pugh | 19 |
Junaid Bajwa | 18 |
Joanna Horobin | 15 |
Richard Bryce | 15 |
Richard Brooman | 9 |
Graham Rich | 9 |
David Jackson | 9 |
Hanan Al Suwaidi | 6 |
Madhu Davies | 5 |
Alastair R. MacGregor | 5 |
Rohit Batta | 4 |
- Bourse
- Insiders
- Colin Hunter
- Connexions Sociétés